PERTH, Australia – Sydney-based Kazia Therapeutics Ltd. has begun a U.S. phase II trial in glioblastoma with lead candidate GDC-0084, in-licensed from Roche Holding AG unit Genentech.
PERTH, Australia – Pharmaceutical companies wanting to submit new drug applications in Australia now have additional pathways thanks to new drug legislation aimed at speeding access to therapies.
PERTH, Australia – Pharmaceutical companies wanting to submit new drug applications in Australia now have additional pathways thanks to new drug legislation aimed at speeding access to therapies.
PERTH, Australia – Australia is launching an online "innovation showcase" that aims to catalogue and track the progress of innovations in the pharmaceutical, medical technology and digital health space across Australia in real time on a public platform open to investors, health practitioners and the public.
PERTH, Australia – Australia is launching an online "innovation showcase" that aims to catalogue and track the progress of innovations in the pharmaceutical, medical technology and digital health space across Australia in real time on a public platform open to investors, health practitioners and the public.
